Ikena Oncology, Inc. (IKNA)
- Previous Close
1.1300 - Open
1.1450 - Bid --
- Ask --
- Day's Range
1.1250 - 1.2424 - 52 Week Range
0.9710 - 1.9400 - Volume
37,025 - Avg. Volume
93,543 - Market Cap (intraday)
55.014M - Beta (5Y Monthly) 0.48
- PE Ratio (TTM)
-- - EPS (TTM)
-1.0200 - Earnings Date Aug 6, 2025 - Aug 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.00
Ikena Oncology, Inc., an oncology company, focuses on developing therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. It develops IK-595, a molecular glue designed to trap MEK and RAF in an inactive complex. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.
ikenaoncology.comRecent News: IKNA
View MorePerformance Overview: IKNA
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IKNA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IKNA
View MoreValuation Measures
Market Cap
54.53M
Enterprise Value
-62.33M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.43
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-20.44%
Return on Equity (ttm)
-33.30%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-49.23M
Diluted EPS (ttm)
-1.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
124.39M
Total Debt/Equity (mrq)
5.97%
Levered Free Cash Flow (ttm)
-31.55M